Dutch 
Staff
Sven Bostyn 
Assistant professor
 
Institute for Information Law (IViR)

Visiting address
Korte Spinhuissteeg 3
1012 CG Amsterdam
The Netherlands

Post address
Kloveniersburgwal 48
1012 CX Amsterdam
The Netherlands

kamer B2.09
tel: +31 20 - 525 7382
fax: +31 20 - 525 3033
 


Curriculum Vitae
Sven Bostyn, Lic.Jur. (Gent), LL.M. (Stockholm), PhD (Maastricht), Assistant Professor of Intellectual Property Law, Institute for Information Law (IVIR), University of Amsterdam, Senior Lecturer in Intellectual Property Law at the University of Liverpool and consultant in IP.

He is research fellow at the International Institute of Infonomics and adjunct research fellow at the Intellectual Property Research Institute, Centre for Commercial Law Studies, Queen Mary and Westfield College, London. Since 2001 he is also acting professorial lecturer at the WIPO Intellectual Property Law Course in Torino and the post-graduate IP course in Zürich (ETHZ). He was member of a Scientific Advisory Committee at the Dutch Royal Academy of Sciences (Gene Patents Committee), and is also member of and rapporteur at the Expert Group of the European Commission (DG Internal Market and DG Research) for the evaluation of Directive 98/44/EC relating to the legal protection of biotechnological inventions. He is also involved in a number of international research projects.

He has published extensively in Dutch and international journals in the field of patent law and biotechnological and computer implemented inventions, and is the author of ‘Enabling Biotechnological Inventions in Europe and the United States. A study of the patentability of proteins and DNA sequences with special emphasis on the disclosure requirement, Eposcript Series, nr. 4, EPO, München, 2001, +/- 340 pp., and of a Study prepared for the European Commission, ‘Patenting DNA Sequences (Polynucleotides) and Scope of Protection in the European Union: An Evaluation, European Communities, 2004, +/- 140 pp. He is also co-editor of the Journal of International Biotechnology Law. He is a frequent speaker on international conferences.  His fields of interest are: law and economics of IP rights. The tension between competition and monopoly rights. 

Within the domain of patent law, major attention is directed towards the patentability of biotechnological inventions, plant variety right protection, plant and animal patents, methods of medical treatment, pharmaceutical inventions, computer implemented innovations, and in general (compulsory) licensing in patent and know-how matters. Also the relationship between patent law and health care, clinical trials, biodiversity, access to genetic resources and traditional knowledge and IP. Competition law issues relating to intellectual property rights. This all in comparative perspective, with major emphasis on Europe (EPO, European Union, national states) and the United States, WIPO and WTO developments.


Publications

No Contact with the Human Body, Please! Patentability of Diagnostic Method Inventions after G01/04, European Intellectual Property Review, 2007-6, p. 238-244.

When the referral to the Enlarged Board of Appeal (EBA) was made in respect of diagnostic method inventions, high expectations were present that the decision would bring an end to existing confusion and legal uncertainty with regard to diagnostic method patent applications. As will be seen further in this comment, the EBA had not entirely delivered.

09.08.2007


DNA patents in Europe: Controversy remains, paper presented at the conference The ethics of patenting human genes and stem cells, organised by the University of Copenhagen, Danish Council of Ethics and Biotik, 28 September 2004.

10.05.2005


Patenting DNA sequences (polynucleotides) and scope of protection in the European Union: an evaluation : Background study for the European Commission within the framework of the Expert Group on Biotechnological Inventions, European Commission; Directorate-general for Research Food Quality and Safety, 2004.

27.01.2005


Enabling biotechnological inventions in Europe and the United States: a study of the patentability of proteins and DNA sequences with special emphasis on the disclosure requirement, European Patent Office, 2001.

27.01.2005


03.07.2012